bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Hypertension
Lipoproteins, HDL Cholesterol
 Resources from HONselect
Guidelines May Miss Need for Statins in Many U.S. Blacks
Individualized scans of the arteries may be a better means of spotting patients at risk, researchers say

By E.J. Mundell

SATURDAY, March 18, 2017 (HealthDay News) -- U.S. medical organizations have conflicting guidelines on the use of cholesterol-lowering statin drugs in blacks, a new study finds.

Researchers say that about one in four black Americans who are recommended to take a statin under guidelines from the American College of Cardiology/American Heart Association would no longer qualify for such therapy under new guidelines from the U.S. Preventive Services Task Force (USPSTF).

The USPSTF is an influential government-appointed group whose decisions often influence health care, including insurance coverage.

The new study was led by Dr. Venkatesh Murthy of the University of Michigan, in Ann Arbor. His team noted that while many studies have used artery scans to assess the need for statins by white patients, no such studies have focused on black patients.

However, compared with whites, black Americans are at higher risk of developing heart disease linked to plaque buildup in the arteries ("hardening of the arteries").

So, would the new USPSTF guidelines on statin use be accurate for black patients? To find out, Murthy's team compared statin "eligibility" for more than 2,800 black patients, aged 40 to 75.

The study authors reported that about one-quarter of black people who would be recommended to take a statin under the ACC/AHA guidelines wouldn't be eligible under the new USPSTF advisory.

This suggests that the government panel's guidelines may be less accurate at spotting black patients who need the therapy, the researchers said.

Murthy's group believes that, overall, just 38 percent of high-risk black Americans would get a statin under the USPSTF guidelines, meaning that "significant numbers" of people would miss out on the cholesterol-lowering treatment.

What to do? According to the researchers, using scans to measure each patient's artery calcification levels might help spot patients in need. This type of test has the potential to personalize a patient's individual need for statin treatment, the authors explained.

Two cardiologists agreed.

"This study brings us back to the critical need to appreciate the uniqueness of different populations -- whether based on gender, race, or ethnicity -- and to evaluate results of trials or impact of guideline recommendations with regard to these differences," said Dr. Stacey Rosen. She's vice president of women's health at Northwell Health's Katz Institute for Women's Health in New Hyde Park, N.Y.

"We have certainly learned in other clinical areas -- cardiovascular disease in women, [high blood pressure] in African Americans, or diabetes in Latinos -- that 'one-size-does-not-fit-all,'" Rosen said.

Dr. Satjit Bhusri is a heart specialist at Lenox Hill Hospital in New York City. He agreed with the researchers that "the use of calcium scoring by CT scan is best for early detection of heart disease; it is specific for each patient, and its benefits for early prevention are immense." But he believes such testing should be available to all patients, regardless of race.

The study was published online March 18 in the journal JAMA Cardiology and will be presented at the annual meeting of the American College of Cardiology, in Washington, D.C.

More information

The U.S. Food and Drug Administration has more on statins.

SOURCES: Stacey Rosen, M.D., vice president, women's health, Northwell Health's Katz Institute for Women's Health, New Hyde Park, N.Y.; Satjit Bhusri, M.D., cardiologist, Lenox Hill Hospital, New York City; JAMA Cardiology, news release, March 18, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=720702

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Research Personnel
Arteries
Women
Heart
Therapeutics
Risk
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact